this is from the Ivor Cummins link.... thanks...
as we can all see in the data... we can begin to ask the questions.....
and make new statements about the risk reward scenario....
I have been saying this... to the vaccine nazis... about healthy kids...
"Concerning
children, since covid remains mostly asymptomatic or mild in them anyway, and since vaccination cannot prevent infection and infectiousness, the vaccination of children and even of young low-risk adults becomes increasingly difficult to justify, especially given the very real
vaccine-associated cardiovascular risks to them (e.g. teen myocarditis and cerebral blood clots)."
https://swprs.org/covid-vaccines-the-good-the-bad-the-ugly/
....
Thus, vaccine protection even against severe disease will likely further decrease due to
new variants, or, in the very worst case, will turn into
antibody-dependent disease enhancement (ADE), if high levels of non-neutralizing antibodies aggravate the infection. Indeed, this is what happened in the case of vaccines against SARS-1 and dengue fever.
To prevent such a decrease in protection against severe disease, or to restore short-term protection against infection and mild disease, updated
“booster shots” will likely become necessary. (
Update: On July 29, Israel
announced “booster shots” for people over 60 years of age.)
However, there is a
very real risk that additional vaccinations, which inject or induce the coronavirus spike protein, could substantially increase the risk of serious
cardiovascular and neurological adverse events, such as strokes, GBS and heart muscle inflammation. Globally, covid vaccines may already have killed
tens of thousands of people. Alternatives include safer
oral vaccine candidates or medically supervised, low-dose oral
live virus challenges in low-risk people.
Furthermore, the
millions of people who were told that vaccination will protect them against a coronavirus infection will soon have to realize (once again) that this is not the case: instead, most of them will get infected anyway. On the positive side, this may actually provide additional mucosal immunity to large parts of the population while being mostly protected against severe disease.
Indeed, data
from Israel as well as
recent studies all indicate that a previous coronavirus infection continues to offer the
best protection against future infections and disease.
In contrast, vaccination cannot achieve
“sterile immunity” against infection and infectiousness. Thus, the whole idea of
“vaccination certificates” has become obsolete – at least from a medical and epidemiological perspective – and should be rejected: the claim that it’s just “the unvaccinated” that are driving outbreaks – a claim
made by many authorities – is simply false.
For instance, just this week a “fully vaccinated” Australian managed to
pre-symptomatically infect about 60 people at a party in the United States. Many similar stories have already been reported
in Europe and Israel: fully vaccinated people can easily transmit the virus even to large groups. Hence, imposing “vaccination certificates” or “green passes” may only serve a
political purpose.
(
Update: New data from Israel
shows that “only 20%” of fully vaccinated people have infected others in public spaces. While authorities claim that this is a success, in reality, it is
not any different from unvaccinated people, thus confirming zero effectiveness against infection
and transmission.)
In many countries,
mass vaccination campaigns have themselves
triggered large coronavirus outbreaks (
“post-first dose spike”), possibly due to a combination of vaccine-induced temporary immune suppression and infections at large indoor vaccination centers visited by thousands of people. The vaccine-induced temporary immune suppression may also explain the frequently observed post-vaccination
appearance of shingles (i.e. herpes zoster reactivation).
Concerning
children, since covid remains mostly asymptomatic or mild in them anyway, and since vaccination cannot prevent infection and infectiousness, the vaccination of children and even of young low-risk adults becomes increasingly difficult to justify, especially given the very real
vaccine-associated cardiovascular risks to them (e.g. teen myocarditis and cerebral blood clots).
A look at covid data in places like
Israel, the UK and Portugal – which were first in Europe to experience the Delta variant summer wave – confirms that, while infections have skyrocketed, hospitalizations have remained rather low and deaths have remained very low so far (see charts below). In contrast, in
countries with a low vaccination rate – such as India, Russia, as well as many Asian and African countries, Delta covid deaths have reached all-time record levels (see below).
In conclusion, and as
argued previously, vaccine protection against infection and “mild disease” has pretty much collapsed, whereas protection against severe disease and death remains at a reasonable level, with the partial exception of the most senior citizens and especially nursing home residents, some of whom
have never mounted a neutralizing antibody response to the vaccine. Moreover, future coronavirus variants will likely achieve
additional immune evasion.
Given the current situation and outlook, it may once again be emphasized that research and implementation of
early treatment options for high-risk patients – especially anti-viral, anti-inflammatory (immuno-modulatory) and anti-thrombotic treatment – should be a top priority.
